The Newer Fluoroquinolones

Maureen K Bolon*

*Corresponding author for this work

Research output: Contribution to journalReview article

60 Citations (Scopus)

Abstract

Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin.

Original languageEnglish (US)
Pages (from-to)1027-1051
Number of pages25
JournalInfectious Disease Clinics of North America
Volume23
Issue number4
DOIs
StatePublished - Dec 1 2009

Fingerprint

Fluoroquinolones
Safety
Levofloxacin
Ciprofloxacin
Streptococcus pneumoniae
Epidemiology
Pharmacology

Keywords

  • Antiinfective agents
  • Fluoroquinolones
  • Microbial drug resistance
  • Pharmacokinetics
  • Pharmacology
  • Therapeutic use

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{da461cee4e744590bab2f554895ec451,
title = "The Newer Fluoroquinolones",
abstract = "Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin.",
keywords = "Antiinfective agents, Fluoroquinolones, Microbial drug resistance, Pharmacokinetics, Pharmacology, Therapeutic use",
author = "Bolon, {Maureen K}",
year = "2009",
month = "12",
day = "1",
doi = "10.1016/j.idc.2009.06.003",
language = "English (US)",
volume = "23",
pages = "1027--1051",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "4",

}

The Newer Fluoroquinolones. / Bolon, Maureen K.

In: Infectious Disease Clinics of North America, Vol. 23, No. 4, 01.12.2009, p. 1027-1051.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The Newer Fluoroquinolones

AU - Bolon, Maureen K

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin.

AB - Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin.

KW - Antiinfective agents

KW - Fluoroquinolones

KW - Microbial drug resistance

KW - Pharmacokinetics

KW - Pharmacology

KW - Therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=70350726100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350726100&partnerID=8YFLogxK

U2 - 10.1016/j.idc.2009.06.003

DO - 10.1016/j.idc.2009.06.003

M3 - Review article

VL - 23

SP - 1027

EP - 1051

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

SN - 0891-5520

IS - 4

ER -